Rascol O - Search Results

1

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W. Schapira AH, et al. Among authors: rascol o. Eur J Neurol. 2013 Jan;20(1):180-7. doi: 10.1111/j.1468-1331.2012.03822.x. Epub 2012 Jul 31. Eur J Neurol. 2013. PMID: 22845710 Clinical Trial.

2

Perspectives on recent advances in the understanding and treatment of Parkinson's disease.

Schapira AH, Agid Y, Barone P, Jenner P, Lemke MR, Poewe W, Rascol O, Reichmann H, Tolosa E. Schapira AH, et al. Among authors: rascol o. Eur J Neurol. 2009 Oct;16(10):1090-9. doi: 10.1111/j.1468-1331.2009.02793.x. Epub 2009 Aug 30. Eur J Neurol. 2009. PMID: 19723294 Review.

3

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Salin L, Juhel N, Poewe W; Pramipexole ER Studies Group. Schapira AH, et al. Among authors: rascol o. Neurology. 2011 Aug 23;77(8):767-74. doi: 10.1212/WNL.0b013e31822affdb. Epub 2011 Aug 10. Neurology. 2011. PMID: 21832216 Clinical Trial.

4

Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial.

Poewe W, Rascol O, Barone P, Hauser RA, Mizuno Y, Haaksma M, Salin L, Juhel N, Schapira AH; Pramipexole ER Studies Group. Poewe W, et al. Among authors: rascol o. Neurology. 2011 Aug 23;77(8):759-66. doi: 10.1212/WNL.0b013e31822affb0. Epub 2011 Aug 10. Neurology. 2011. PMID: 21832218 Clinical Trial.

5

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W; Pramipexole ER Studies Group. Schapira AH, et al. Among authors: rascol o. Eur J Neurol. 2013 Jan;20(1):50-6. doi: 10.1111/j.1468-1331.2012.03712.x. Epub 2012 Apr 27. Eur J Neurol. 2013. PMID: 22537207 Clinical Trial.

6

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.

Hauser RA, Schapira AH, Barone P, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W; Pramipexole ER Studies Group. Hauser RA, et al. Among authors: rascol o. Eur J Neurol. 2014 May;21(5):736-43. doi: 10.1111/ene.12375. Eur J Neurol. 2014. PMID: 24834511 Free PMC article. Clinical Trial.

7

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P. Ferreira JJ, et al. Among authors: rascol o. Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25. Eur J Neurol. 2019. PMID: 30681754 Free PMC article. Clinical Trial.

8

Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.

Hauser RA, Bronzova J, Sampaio C, Lang AE, Rascol O, Theeuwes A, van de Witte SV; Pardoprunox Study Group. Hauser RA, et al. Among authors: rascol o. Eur Neurol. 2009;62(1):40-8. doi: 10.1159/000216839. Epub 2009 Apr 30. Eur Neurol. 2009. PMID: 19407454 Clinical Trial.

9

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.

Rascol O, Bronzova J, Hauser RA, Lang AE, Sampaio C, Theeuwes A, van de Witte SV. Rascol O, et al. Parkinsonism Relat Disord. 2012 May;18(4):370-6. doi: 10.1016/j.parkreldis.2011.12.006. Epub 2012 Feb 7. Parkinsonism Relat Disord. 2012. PMID: 22316635 Clinical Trial.

10

The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Schrag AE, Brooks DJ, Brunt E, Fuell D, Korczyn A, Poewe W, Quinn NP, Rascol O, Stocchi F. Schrag AE, et al. Among authors: rascol o. Clin Neuropharmacol. 1998 May-Jun;21(3):169-75. Clin Neuropharmacol. 1998. PMID: 9617508 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters